A novel, potent series of indole analogs were recently developed as MR antagonists, culminating in 14. This compound represents the first MR antagonist in this class of molecules, exhibiting picomolar binding affinity and in vivo blood pressure lowering at pharmaceutically relevant doses.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm701186zDOI Listing

Publication Analysis

Top Keywords

s-n-{3-[1-cyclopropyl-1-24-difluoro-phenyl-ethyl]-1h-indol-7-yl}-methanesulfonamide potent
4
potent nonsteroidal
4
nonsteroidal functional
4
functional antagonist
4
antagonist mineralocorticoid
4
mineralocorticoid receptor
4
receptor novel
4
novel potent
4
potent series
4
series indole
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!